Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

30,114 total articles

Momentus Wins LASP Hosting Contract; Shares Climb After Deal

Momentus Wins LASP Hosting Contract; Shares Climb After Deal

Momentus Inc. (NASDAQ:MNTS) reported a commercial contract to host the University of Colorado Boulder’s Laboratory for Atmospheric and Space Physics (LASP) Occultation Wave Limb Sounder (OWLS) instruments on its Vigoride-9 Orbital Service Vehicle, prompting a 19% jump in the company’s shares. The mission, planned for 2027, will measure atmospheric …

AST SpaceMobile Shares Rise After Successful BlueBird Satellite Launch

AST SpaceMobile Shares Rise After Successful BlueBird Satellite Launch

AST SpaceMobile Inc. (NASDAQ: ASTS) saw its shares climb 4.9% in premarket trading Wednesday after launching BlueBird satellites 8, 9 and 10 on a SpaceX Falcon 9 from Cape Canaveral. The newly deployed satellites are intended to deliver peak data speeds approaching 200 Mbps directly to standard smartphones, and represent a step up in capacity versu…

Tadawul slips 0.27% as insurance, media and real estate sectors weigh

Tadawul slips 0.27% as insurance, media and real estate sectors weigh

Saudi Arabia's benchmark ended lower on Wednesday with the Tadawul All Share down 0.27%. Losses in Media & Publishing, Insurance and Real Estate Development sectors contributed to the retreat. Gulf Insurance Group led winners, while Aljazira Takaful, Saudi Cement and Rabigh Refining & Petrochemical were among the biggest decliners. Market breadth f…

Pattern Group Stock Rebounds After Secondary Offering Priced at $19

Pattern Group Stock Rebounds After Secondary Offering Priced at $19

Pattern Group shares rose 2.0% in pre-market trading after pre-IPO investor Knox Lane LP priced an 8 million-share secondary offering at $19.00 per share. The deal - which will not provide proceeds to the company - was underwritten by J.P. Morgan and Goldman Sachs and includes a 30-day option to sell up to an additional 1.2 million shares. The clea…

Morgan Stanley Sees Better Upside in Charles River, Cautions on IQVIA Amid AI and Insourcing Concerns

Morgan Stanley Sees Better Upside in Charles River, Cautions on IQVIA Amid AI and Insourcing Concerns

Morgan Stanley moved to upgrade Charles River Laboratories to Overweight with a $220 price target while downgrading IQVIA Holdings to Equal-weight and trimming its price target to $200. The firm cited signs of recovery in preclinical research driven by improving biopharma funding and portfolio moves that sharpen Charles River's focus. For IQVIA, Mo…

Hims & Hers Shares Edge Higher Ahead of Key FDA Advisory Meeting

Hims & Hers Shares Edge Higher Ahead of Key FDA Advisory Meeting

Hims & Hers Health Inc. traded slightly higher in pre-market action, keeping near $31.54 after attention around a Leerink Partners note that outlined how a July regulatory review could enable the telehealth company to enter peptide compounding. The company is being valued largely on regulatory optionality ahead of a July 23-24 Pharmacy Compounding …

Hexagon B Shares Jump After Insider Buys 55,000 Shares

Hexagon B Shares Jump After Insider Buys 55,000 Shares

Hexagon AB ser. B rose 4.8% to 84.08 SEK following a series of insider purchases totaling 55,000 shares valued at about 4.4 million SEK. The move came amid a cautiously positive session for European equities and a modest uptick in Sweden's OMXS30 index. Technical pressure on the stock since the Octave Intelligence spin-off in May 2026 has left the …

Capricor Therapeutics Shares Rise Ahead of August FDA Deadline

Capricor Therapeutics Shares Rise Ahead of August FDA Deadline

Capricor Therapeutics (CAPR) climbed in pre-market trading, supported by an approaching FDA PDUFA target date for its lead cell therapy Deramiocel and a broadly bullish analyst consensus. Elevated short interest and sector-specific investor flows into near-term catalysts are amplifying price moves even as major indexes show mixed performance.

Investors Flee After Snap Unveils Hefty $2,195 SPECS Headset

Investors Flee After Snap Unveils Hefty $2,195 SPECS Headset

Snap shares plunged 9.6% after CEO Evan Spiegel unveiled SPECS, a self-contained augmented reality headset priced at $2,195 and presented as the next generation 'computer of the future.' Analysts questioned the device's bulk and price, calling it closer to a developer kit than a mainstream fashion accessory. The launch comes as Snap narrows its wor…

Leidos Shares Slip After BofA Downgrade, Analyst Cuts Add Pressure

Leidos Shares Slip After BofA Downgrade, Analyst Cuts Add Pressure

Leidos Holdings fell in pre-market trading after BofA Securities lowered its rating to Neutral and slashed the price target to $125 from $200, citing mounting pressure in the companys healthcare portfolio. The downgrade follows a recent cut from Jefferies and comes amid news that the Defense Health Agency plans to move away from Leidos as the lead…

OHB Shares Drop on Rights Issue, KKR Stake Sale and Technical Pressure

OHB Shares Drop on Rights Issue, KKR Stake Sale and Technical Pressure

OHB SE shares slid about 7.9% to €404 in today’s trading as investors digested a June 15, 2026 announcement of a roughly €500 million rights-based capital increase aimed mainly at institutional buyers and a concurrent plan by KKR to place a large portion of its roughly 29% stake. The moves would lift free float from about 6% to near 26%, creating a…

Citi Revises 2028 Earnings Base, Boosts Price Targets on AMAT, LRCX and KLAC as WFE Demand Surges

Citi Revises 2028 Earnings Base, Boosts Price Targets on AMAT, LRCX and KLAC as WFE Demand Surges

Citi raised price targets for Applied Materials, Lam Research and KLA after revising its wafer fab equipment (WFE) model and rolling forward valuations to a calendar year 2028 earnings base. The bank now sees materially larger bull-case WFE spending through 2028 and points to structural NAND demand growth tied to agentic AI and constrained DRAM sup…